LXE Hearing, the parent company of Eargo, Lexie Hearing, Go Hearing, and hearX, has announced it is winding down its US operations after failing to identify a viable path forward following restructuring efforts.
LXE Hearing has confirmed it is shutting down its US business, marking a significant development in the over-the-counter (OTC) and direct-to-consumer (DTC) hearing aid sector. The company, whose portfolio includes Eargo, Lexie Hearing, Go Hearing, and hearX, announced the decision in a statement posted to its website, citing an inability to secure a viable restructuring or strategic transaction.
“Our parent company, LXE Hearing, has begun a wind-down of its US operations,” the company says on its site. “This decision follows extensive efforts to restructure the business and pursue strategic transactions to maintain support for our customers. Unfortunately, despite these efforts, we were unable to identify a viable path forward.”
LXE Hearing was formed through the merger of Eargo and hearX, combining Eargo’s DTC hearing aid platform with hearX’s clinically validated hearing health technology, which is deployed in more than 70 countries. The combined entity had positioned itself as a full-suite hearing health company — spanning detection, diagnosis, and intervention.
Impact on Customers
According to the company’s announcement, customer service representatives will remain available through at least Sept 15, 2026, and will be able to assist with troubleshooting, eligible refunds, and active warranty claims. Warranty claims submitted through that date will continue to be processed, though the company notes it is still developing plans for warranty administration beyond that period.
The company’s mobile applications will continue to operate normally in the near term, but LXE Hearing cautions that app download availability will not be maintained indefinitely. The announcement did not specify whether future software or firmware updates — including bug fixes or compatibility patches for new phone operating systems — will be issued.
Customers needing replacement parts, such as tips, domes, or wax guards, are encouraged to contact customer service directly, though the company notes that availability may be limited based on existing inventory and resources.
A Notable Exit from the OTC Market
The closure represents one of the more notable exits from the OTC hearing aid space since the FDA established the OTC hearing aid category in 2022. Lexie Hearing had been named among TIME’s 100 Most Influential Companies in 2023 for its Powered by Bose line of OTC hearing aids, and Lexie products were sold in more than 16,000 retail locations nationwide. Eargo had also expanded its retail footprint, including a partnership with Best Buy.
Go Hearing, another brand under the LXE umbrella, offered rechargeable OTC devices including the Go Ultra with hands-free Bluetooth streaming, targeting accessibility and simplicity for first-time hearing aid users.
Customer Communication Going Forward
LXE Hearing says all future updates related to the transition will be communicated directly to customers via email, and it is encouraging users to confirm or update their email addresses through the company’s app or by contacting customer service.
The company did not announce any asset sales, brand acquisitions, or third-party partnerships related to the wind-down at the time of this writing.
